bendamustine hydrochloride has been researched along with Orphan Diseases in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Liu, Z; Mandernach, MW; Markham, M | 1 |
1 other study(ies) available for bendamustine hydrochloride and Orphan Diseases
Article | Year |
---|---|
Marginal zone lymphoma-associated antiphospholipid antibodies successfully treated with bendamustine rituximab.
Topics: Antibodies, Antiphospholipid; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Immunological; Antiphospholipid Syndrome; Bendamustine Hydrochloride; Diagnosis, Differential; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma, B-Cell, Marginal Zone; Male; Middle Aged; Rare Diseases; Rituximab; Treatment Outcome | 2019 |